Clinical trial
Insulin Analogue With Continuous Glucose Monitoring System (CGMS) Measurement
NCT00354939 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00354939 |
|---|---|
| Title | Insulin Analogue With Continuous Glucose Monitoring System (CGMS) Measurement |
| Official title | 10-week, Open, National, Multicenter Clinical Trial to Evaluate the Safety of Insulin Glargine in Type 2 Diabetes Mellitus Patients, on Intensified Conventional Therapy (ICT) |
| Acronym | SAFIR |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus Type 2 |
| Intervention type | Drug |
| Interventions | Insulin glargine |
| Enrollment | 480 |
| Start date | Oct 1, 2003 |
| Primary completion | Mar 1, 2004 |
| Completion | Mar 1, 2004 |
| First posted | Jul 20, 2006 |
| Last update posted | Aug 31, 2010 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: